Novartis Avidity Biosciences in talks
Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023. Bloomberg | Bloomberg | Getty Images Swiss pharmaceutical giant Novartis has agreed to buy biotechnology company Avidity Biosciences for about $12 billion, the company said Sunday. Novartis will pay Avidity shareholders $72 a share in…